The United States could safely drop tetanus and diphtheria booster shots for adults and save an estimated $1 billion a year, ...

GENEVA, 15 July 2025–Lenacapavir–a long-acting, six-monthly injectable antiretroviral medicine manufactured by Gilead Sciences–is now recommended by the World Health Organization as an additional HIV ...

LONDON (AP) — More than 14 million children did not receive a single vaccine last year — about the same number as the year ...

A newly approved HIV prevention drug, lenacapavir, is set to be introduced in at least nine countries in early 2026, and Rwanda could be among the first to deploy it, government and World Health ...

A million more children completed the critical three-dose vaccination against diseases like diphtheria, tetanus and whooping ...

Here’s what else you need to know to get up to speed and on with your day.

As Professor of Infectious Diseases and Microbiology Paul Griffin explains in a recent piece for The Conversation, Stratus is ...

LEN is the first long-acting PrEP product that requires only two injections per year, offering an appealing alternative to ...

An estimated 14.3 million children globally remain unvaccinated and vulnerable to vaccine-preventable illnesses – meaning ...

The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, ...